CGTX – cognition therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Cognition Therapeutics, Inc. (NASDAQ: CGTX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $11.00 price target on the stock.
Life Sciences Investor Forum: Presentations Now Available for Online Viewing
Cognition Therapeutics Reports Financial Results for the Third Quarter 2024 and Provides Business and Clinical Update
Cognition Therapeutics to Present at Zacks SCR Life Sciences Investor Forum
Cognition Therapeutics, Inc. (NASDAQ: CGTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Form 10-Q COGNITION THERAPEUTICS For: Sep 30
Form 8-K COGNITION THERAPEUTICS For: Nov 13
Form 8-K COGNITION THERAPEUTICS For: Oct 01
Form 8-K COGNITION THERAPEUTICS For: Sep 12
Form 8-K COGNITION THERAPEUTICS For: Aug 28
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.